BRIEF published on 09/12/2024 at 15:18, 25 days 17 hours ago Vanguard Discloses Position in SEGRO plc Form 8.3 Takeover Code Shareholding Vanguard SEGRO
PRESS RELEASE published on 09/12/2024 at 15:18, 25 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Darktrace plc The Vanguard Group, Inc. discloses a 2.85% ownership position in Darktrace plc as of 11 Sep 2024, with 19,992,921 ordinary shares. Details in FORM 8.3 Disclosure Vanguard Group Ownership Position Relevants Securities Darktrace Plc
PRESS RELEASE published on 09/12/2024 at 15:17, 25 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc The Vanguard Group, Inc. discloses a 4.76% stake in Network International Holdings plc as of 11th September 2024. Details of securities and derivatives disclosed in Form 8.3 Form 8.3 Securities Disclosure Vanguard Group Financial Holdings Network International Holdings
BRIEF published on 09/12/2024 at 15:17, 25 days 17 hours ago The Vanguard Group Discloses Position in Hargreaves Lansdown plc Disclosure Takeover Code Vanguard Stock Hargreaves Lansdown
PRESS RELEASE published on 09/12/2024 at 15:16, 25 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Rightmove plc The Vanguard Group, Inc. discloses a 4.70% interest in Rightmove plc. Additional disclosure includes dealings in 0.1p ordinary shares Disclosure The Vanguard Group Dealings Interests Rightmove Plc
BRIEF published on 09/12/2024 at 15:15, 25 days 17 hours ago Vanguard Group Discloses Position in Smith (DS) plc Takeover Code Stock Purchase Vanguard Group Public Disclosure Smith (DS) Plc
PRESS RELEASE published on 09/12/2024 at 15:14, 25 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc The Vanguard Group, Inc. discloses a 5.93% stake in Virgin Money UK plc as of 11 September 2024 Disclosure The Vanguard Group Financial Disclosure Stake Virgin Money UK Plc
BRIEF published on 09/12/2024 at 15:14, 25 days 17 hours ago The Vanguard Group, Inc.: Disclosure on Spirent Communications plc Securities Disclosure Takeover Code Vanguard Group Spirent Communications
PRESS RELEASE published on 09/12/2024 at 15:13, 25 days 17 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.12% stake in SEGRO plc as of 11 September 2024 according to Form 8.3 under the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure SEGRO PLC
BRIEF published on 09/12/2024 at 15:13, 25 days 17 hours ago The Vanguard Group, Inc. Discloses Position in REA Group Ltd Securities Form 8.3 Vanguard Group Financial Disclosure REA Group
Published on 10/07/2024 at 23:00, 9 hours 50 minutes ago Cerrado Gold Appoints Andrew Croal as Chief Technical Officer
Published on 10/07/2024 at 23:00, 9 hours 50 minutes ago Condor Resources Terminates Option Agreement on Soledad Project
Published on 10/07/2024 at 22:30, 10 hours 20 minutes ago Braille Energy Systems Inc. Provides Update on EARLYALERT Lithium Battery Warning System
Published on 10/08/2024 at 08:32, 18 minutes ago Blue Cap AG: Successful sale of Neschen Coating GmbH above net asset value valuation
Published on 10/08/2024 at 08:00, 50 minutes ago Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Published on 10/08/2024 at 08:00, 50 minutes ago Dalata Hotel Group PLC: POS-Transaction in Own Shares
Published on 10/08/2024 at 07:45, 1 hour 5 minutes ago Marinomed Biotech AG publishes remarkable results showing alleviation of allergic eye inflammation in patients treated with Tacrolimus eye drops in peer-reviewed journal
Published on 10/08/2024 at 07:30, 1 hour 20 minutes ago Nordex Group receives orders totalling 500 MW from Canada
Published on 10/08/2024 at 08:30, 20 minutes ago Edenred invests in the Shift4Good fund to support the emergence of smarter, more responsible mobility
Published on 10/08/2024 at 08:30, 20 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 30/09/2024 to 04/10/2024
Published on 10/08/2024 at 08:07, 43 minutes ago Reporting on share buyback transactions carried out between October 1 and October 4, 2024
Published on 10/08/2024 at 08:00, 50 minutes ago MEDESIS PHARMA to participate to the World Congress for Clinical Trials in Alzheimer’s Disease, in Madrid at the end of October 2024 (CTAD, Clinical Trials Alzheimer’s Disease)
Published on 10/08/2024 at 08:00, 50 minutes ago NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.